Summary

Global Antacids Market Size

Global antacids Market will be expected to cross US$ 9.70 billion by 2032 with a CAGR of 3.89 from 2024 to 2032. This growth has been fostered by the rising incidence of gastrointestinal disorders as well as improved lifestyle, and increased access to health care, which speaks volumes of the global need for effective, and easy to use antacids.


Global Antacids Market Definition

Most antacids work by breaking down the acid found in the stomach in order to help with cases of heartburn, indigestion and acid reflux. They include some required materials like aluminum hydroxide, magnesium hydroxide, calcium carbonate, sodium bicarbonate. Antacids have the capability to counter acidic stomach through a process of making the stomach pH level higher. This assists to reduce pain that is resultant from high levels of gastric acid secretion in the stomach which may culminate to diseases like GERD and peptic ulcer.

Common medicines that are used to treat the symptoms that are associated with heartburn and that give a temporary relief include antacids. They are widely sold within the counter markets, and are available in form of tablets, liquids, and chewable tablets. Apart from the treatment of other disorders of the acid type, antacids may be used to suppress signs of gastritis and contribute to the improvement of the mucosal layer of the stomach. They are rather useful for short-term therapeutic purposes and usually cannot be taken in the long term while treating chronic acid-related diseases when other medicines may be advised by the doctor.


Driving Forces for the Antacids Market

Rising Prevalence of Gastrointestinal Disorders

An increase in the prevalence of gastrointestinal diseases such as acid reflux, GERD, and peptic ulcers is another factor that affects the demand for antacids. Therefore, modern development affects the augmentation of these pathologies due to the improper diet, frequent consumption of fast food, irregular food times, and increased levels of stress. As more people complain of heartburn, indigestion, and ‘stomach upset’, more people will be in the market for over the counter treatments like antacids. This is evident in the urban workers who had altered their lifestyle leading to various strains which affected their health. Further, the rising incidence of aging people who are vulnerable to various digestion related disorders advanced the market since the elderly will always look for products and services that they can afford to use to solve their digestion problems.


Increasing awareness and accessibility

As the awareness of the options for antacids and their benefits spreads, the market for them is growing. Concerning the public knowledge and availability of health information on the internet and social media, the population is receiving better information on managing simple diarrhea using OTC drugs. Sales and marketing of these products’ consumer goods are also assisted by pharmacies and retail stores so that these products may reach the consumer. Moreover, the growth of the electronic market places made the access to the antacids easier for the consumers which improved the accessibility of the product. As individuals gain a better and enhanced understanding of what antacids are and where they can get them, a lot of people would utilize them for acid-related symptoms; therefore, the market balloons in size very quickly.


Advancements in Antacid Formulations

New developments in the preparation of antacid has played most of the vital role in the growth of the market. Today’s antacids are available in tablets, liquids, chewable forms and gels to a fit the consumer’s taste as well as requirements. New types, like sugar-free, flavoured and the ones that dissolve quickly also increase its appeal to more people which makes antacids a better product. Creating combination products with other useful active substances, such as simethicone for regulated intestinal gas, gives better solutions for the problems with gastrointestinal tracts. They enhance the efficiency and usability of antacids and increase its popularity among the consumers which contributes to market development.


Lifestyle Changes and Dietary Habits

Increased awareness and consciousness among the people about the excessive use of antacids can be another factor, which is also demanding new and improved products or brands of antacids in the global market. Intake of processed foods and high fat diets and products, caffeine and alcohol contribute a lot to heart burn and other cases of indigestion. These complications are aggravated by busy schedules and stress hence the need for quick and efficient remedy solutions. Because of the immediate action of antacids and ease of access, people consider them as a perfect remedy for solving their digestive problems. This trend is especially seen in the more developed economy countries where the populations are often under lots of pressure with their busy daily schedules and harsh working conditions as well as indulging themselves with lots of fatty foods frequency, and therefore, the ever-rising market for antacids.


Asia Pacific Antacids Market

The Asia Pacific antacids market is growing because of the rising prevalence of GID linked with lifestyle factors and food preferences. From these causes of the digestion problem, one may infer that quick growth of urban centers, fast foods consumption, and pressure have played crucial roles in provoking acid reflux and indigestion. In the same regard, increased consumer knowledge on the availability of OTC medications and ease of access to healthcare facilities contributes to the market’s growth. Major contributors include China, India and Japan due to the large population of patients as well as growing health industries. Variety of ways has been manufactured to reach out to customers through tablets, liquids and chewable help propel the antacid market. Thus, anticipating the further development of the economy, it is pertinent to note that the Asia Pacific region will experience constant growth in the demand for antacids.


Worldwide Antacids Company Analysis

The Antacids market is dominated by key players such as Abbott Laboratories, AstraZeneca plc, Bayer AG, Boehringer Ingelheim International GmbH, Dr. Reddy’s Laboratories Ltd., GlaxoSmithKline plc, Johnson & Johnson, Pfizer Inc., Procter & Gamble Company, Sanofi S.A., Sun Pharmaceutical Industries Ltd., and Takeda Pharmaceutical Company Limited.


Antacids Company News

In March 2024, ENO, previously owned by GSK Consumer Healthcare and now part of Haleon, introduced a new product called "ENO Chewy Bites," chewable antacids available in Tangy Lemon and Zesty Orange flavors. This expansion offers customers more options for managing stomach discomfort.

In March 2023, WonderbellyTM, a company specializing in clean ingredients and medications for digestive health, introduced its Wonderbelly AntacidTM chewable tablets.


Drug Class – Global Antacids Market in 4 Viewpoints –

1. Proton Pump Inhibitors
2. H2 Antagonist
3. Acid Neutralizers
4. Pro-Motility Agents


Formulation Type - Global Antacids Market in 4 Viewpoints –

1. Tablets
2. Liquid
3. Powder
4. Others


Distribution Channel - Global Antacids Market in 3 Viewpoints –

1. Retail Pharmacy
2. Hospital Pharmacy
3. Online Pharmacy


Geography – Global Antacids Market

North America

1. United States
2. Canada

Europe

1. France
2. Germany
3. Italy
4. Spain
5. United Kingdom
6. Belgium
7. Netherlands
8. Turkey

Asia Pacific

1. China
2. Japan
3. India
4. Australia
5. South Korea
6. Thailand
7. Malaysia
8. Indonesia
9. New Zealand

Latin America

1. Brazil
2. Mexico
3. Argentina

Middle East & Africa

1. South Africa
2. Saudi Arabia
3. United Arab Emirates


Company Insights:

• Overviews
• Recent Developments
• Revenue


Company Analysis:

1. Abbott Laboratories
2. AstraZeneca plc
3. Bayer AG
4. Boehringer Ingelheim International GmbH
5. Dr. Reddy’s Laboratories Ltd.
6. GlaxoSmithKline plc
7. Johnson & Johnson
8. Pfizer Inc.
9. Procter & Gamble Company
10. Sanofi S.A.
11. Sun Pharmaceutical Industries Ltd.
12. Takeda Pharmaceutical Company Limited

ページTOPに戻る

Table of Contents

1. Introduction

2. Research Methodology

3. Executive Summary

4. Market Dynamics

4.1 Growth Drivers
4.2 Challenges


5. Global Antacids Market

6. Market Share

6.1 Drug Class
6.2 Formulation Type
6.3 Distribution Channel
6.4 Country


7. Drug Class

7.1 Proton Pump Inhibitors
7.2 H2 Antagonist
7.3 Acid Neutralizers
7.4 Pro-Motility Agents


8. Formulation Type

8.1 Tablets
8.2 Liquid
8.3 Powder
8.4 Others


9. Distribution Channel

9.1 Retail Pharmacy
9.2 Hospital Pharmacy
9.3 Online Pharmacy


10. By Country – Global Antacids Market

10.1 North America

10.1.1 United States
10.1.2 Canada

10.2 Europe

10.2.1 France
10.2.2 Germany
10.2.3 Italy
10.2.4 Spain
10.2.5 United Kingdom
10.2.6 Belgium
10.2.7 Netherlands
10.2.8 Turkey

10.3 Asia Pacific

10.3.1 China
10.3.2 Japan
10.3.3 India
10.3.4 Australia
10.3.5 South Korea
10.3.6 Thailand
10.3.7 Malaysia
10.3.8 Indonesia
10.3.9 New Zealand

10.4 Latin America

10.4.1 Brazil
10.4.2 Mexico
10.4.3 Argentina

10.5 Middle East & Africa

10.5.1 South Africa
10.5.2 Saudi Arabia
10.5.3 UAE


11. Porter’s Five Analysis

11.1 Bargaining Power of Buyers
11.2 Bargaining Power of Suppliers
11.3 Degree of Rivalry
11.4 Threat of New Entrants
11.5 Threat of Substitutes


12. SWOT Analysis

12.1 Strength
12.2 Weakness
12.3 Opportunity
12.4 Threat


13. Company Analysis

13.1 Abbott Laboratories

13.1.1 Overview
13.1.2 Recent Developments
13.1.3 Revenue

13.2 AstraZeneca plc

13.2.1 Overview
13.2.2 Recent Developments
13.2.3 Revenue

13.3 Bayer AG

13.3.1 Overview
13.3.2 Recent Developments
13.3.3 Revenue

13.4 Boehringer Ingelheim International GmbH

13.4.1 Overview
13.4.2 Recent Developments
13.4.3 Revenue

13.5 Dr. Reddy’s Laboratories Ltd.

13.5.1 Overview
13.5.2 Recent Developments
13.5.3 Revenue

13.6 GlaxoSmithKline plc

13.6.1 Overview
13.6.2 Recent Developments
13.6.3 Revenue

13.7 Johnson & Johnson

13.7.1 Overview
13.7.2 Recent Developments
13.7.3 Revenue

13.8 Pfizer Inc.

13.8.1 Overview
13.8.2 Recent Developments
13.8.3 Revenue

13.9 Procter & Gamble Company

13.9.1 Overview
13.9.2 Recent Developments
13.9.3 Revenue

13.10 Sanofi S.A.

13.10.1 Overview
13.10.2 Recent Developments
13.10.3 Revenue

13.11 Sun Pharmaceutical Industries Ltd.

13.11.1 Overview
13.11.2 Recent Developments
13.11.3 Revenue

13.12 Takeda Pharmaceutical Company Limited

13.12.1 Overview
13.12.2 Recent Developments
13.12.3 Revenue